Diligence memo · auto-generated · as of July 2, 2026
AiTA Bio Inc.
AiTA Bio Inc. looks over-valued against its niche peers and is quiet on financing cadence.
Businessfiled
AiTA Bio Inc. operates in Manufacturing, based in NEW YORK.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
AiTA Bio Inc. has raised $10M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $10M on 2025-01-13.
Most recent recorded round closed around 2025-01-13.
Valuation (modeled)modeled
Provath models AiTA Bio Inc. at approximately $36M (range $14M–$68M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.19× the median modeled value of Series A Manufacturing companies in 2025–2027 (62 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 18 mo ago; this sector typically re-raises about every 12 months.
Slightly overdue versus sector cadence.
Comparablesmixed
Capital scale ranks ahead of 79% of Manufacturing peers (3257 compared).
Modeled value ranks above 74% of those peers.
Closest niche peers: Island Hedley Parent LLC, Salt Lake City Distillery, Llc, Bespoken Spirits Inc., C-Motive Technologies, Inc., Hheli. Llc.
Peoplefiled
2 named people on file across officers, directors and signatories.
Risks & flagsmixed
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.